Radical cell therapy tested for Tough-to-Treat autoimmune illnesses
Disease control
Recruiting now
This early-stage study is testing the safety and initial effectiveness of a new cell therapy called BZE2204 for adults with severe autoimmune diseases that have not improved with standard treatments. The therapy involves modifying a patient's own immune cells to target and potent…
Phase: EARLY_PHASE1 • Sponsor: Shanghai Cell Therapy Group Co.,Ltd • Aim: Disease control
Last updated Mar 06, 2026 15:39 UTC